InvestorsHub Logo
Followers 46
Posts 4449
Boards Moderated 0
Alias Born 07/26/2010

Re: ok2buy post# 1323

Thursday, 02/25/2021 10:24:03 AM

Thursday, February 25, 2021 10:24:03 AM

Post# of 2791
Long term story here is just fine...

The data show that Pritumumab ("PTB") successfully blocked 80% of viral entry into cells. Based on these results, PTB will be advanced to laboratory-based animal studies.

https://www.otcmarkets.com/stock/NBIO/news/Nascent-Biotech-Announces-Successful-Pritumumab-In-Vitro-Trial-Data-in-Collaborative-Covid-19-Treatment-Study-with-Syrac?id=290256

It's the short-term rinkydinkystinkypinky way NBIO management treats we retail shareholders with information, lack of information.

In layman-speak: If it trades rinkydinkystinkypinky then trade it like it's a rinkydinkystinkypinky
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NBIO News